Cortexyme, Inc.

Cortexyme, Inc.verified

CRTX

Price:

$1.95

Market Cap:

$234.42M

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Industry

Biotechnology

IPO Date

2019-05-09

Stock Exchange

NASDAQ

Ticker

CRTX

The Enterprise Value as of December 2025 (TTM) for Cortexyme, Inc. (CRTX) is 234.97M

According to Cortexyme, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 234.97M. This represents a change of 235.93% compared to the average of 69.95M of the last 4 quarters.

Cortexyme, Inc. (CRTX) Historical Enterprise Value (quarterly & annually)

How has CRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Cortexyme, Inc. over the last ten years is 444.91M. The current 234.97M Enterprise Value has changed 5.18% with respect to the historical average. Over the past ten years (40 quarters), CRTX's Enterprise Value was at its highest in in the September 2021 quarter at 2.67B. The Enterprise Value was at its lowest in in the December 2022 quarter at -21092607.65.

Quarterly (TTM)
Annual

Average

444.91M

Median

495.21M

Minimum

-22775309.87

Maximum

1.02B

Cortexyme, Inc. (CRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cortexyme, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 178.29%

Maximum Annual Enterprise Value = 1.02B

Minimum Annual Increase = -241.21%

Minimum Annual Enterprise Value = -22775309.87

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202489.50M178.29%
202332.16M-241.21%
2022-22775309.87-107.43%
2021306.48M-58.81%
2020744.12M-26.85%
20191.02B48.73%
2018683.94M-3.49%

Cortexyme, Inc. (CRTX) Average Enterprise Value

How has CRTX Enterprise Value performed in the past?

The current Enterprise Value of Cortexyme, Inc. (CRTX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

32.96M

5-year avg

229.90M

10-year avg

444.91M

Cortexyme, Inc. (CRTX) Enterprise Value vs. Peers

How is CRTX’s Enterprise Value compared to its peers?

Cortexyme, Inc.’s Enterprise Value is greater than Surface Oncology, Inc. (70.21M), greater than Achilles Therapeutics plc (-21604000.00), greater than Landos Biopharma, Inc. (34.13M), less than Jade Biosciences, Inc. (439.38M), greater than Reneo Pharmaceuticals, Inc. (-21710584.00), greater than IGM Biosciences, Inc. (46.85M), greater than TCR2 Therapeutics Inc. (79.12M), greater than Kronos Bio, Inc. (-13835104.00), less than Heat Biologics, Inc. (20.56T), greater than Berkeley Lights, Inc. (42.64M),

Build a custom stock screener for Cortexyme, Inc. (CRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cortexyme, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cortexyme, Inc. (CRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cortexyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cortexyme, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Cortexyme, Inc. (CRTX)?

What is the 3-year average Enterprise Value for Cortexyme, Inc. (CRTX)?

What is the 5-year average Enterprise Value for Cortexyme, Inc. (CRTX)?

How does the current Enterprise Value for Cortexyme, Inc. (CRTX) compare to its historical average?